Effects of Kinesio Taping on Performance

July 18, 2016 updated by: Dr. Suk H. Lee, Texas A&M University San Antonio

Kinesio Taping and Muscular Function in Obese Adults

This study investigated the immediate effects of Kinesio taping on muscular power, strength, endurance, and lower limb fatigue when taping is applied to rectus femoris and around the patella of obese adults based on Kinesio taping techniques.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This is a randomized, double-blind, crossover, and clinical trial. Ethical approval was obtained from the University's Institutional Review Board (#2015-51). Participants were recruited by flyers posted on the University campus. Informed consent was completed by all participants prior to the study procedures. The subjects were obese college students. A total of 13 subjects, four males and nine females (mean age of 24.38 ± 3.01 years, mean percent body fat of 39.10 ± 6.91 % [male: 41.93 ± 7.47 %, female: 38.16 ± 6.91 %]), were enrolled this study. All subjects underwent three different trials which include no taping (NT), placebo taping (PT), and Kinesio taping (KT). All individuals were assessed for peak and mean power, muscular strength, endurance, and muscle fatigue after each condition.

Study Type

Interventional

Enrollment (Actual)

13

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • percent body fat of 25 % in males, 30 % in females or more

Exclusion Criteria:

  • lower limb surgery within previous 6 months
  • presence of any other lower limb joint diseases such as degenerative arthritis, rheumatoid arthritis.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Kinesio taping
All subjects wore an eye mask and the taped leg was covered by clothes for preventing subjects and researchers from identifying different tapings due to double-blinding. Subjects layed down on the mat in a supine position with the hip flexed 30º and the knee flexed 60º. Y type tape was applied from a point 10 cm below the anterior superior iliac spine, bisected at the junction between quadriceps femoris tendon and the patella, ending at its inferior side. And another Y type tape was applied from the tibial tuberosity, bisected at the junction between patella tendon and the patella, ending at its superior side. The first 5 cm tape was not stretched and acted as the anchor. I type tapes were applied downward and inward to the superior and inferior meniscus of the patella respectively.
This study was conducted in a randomized crossover double-blind design. Each subject was tested for muscular power, strength, endurance, and fatigue of the lower extremities under three conditions: 1) NT (no taping), 2) PT (placebo taping, 3M tape) and 3) KT (Kinesio taping). For allocation of treatment sequence, the participants drew straws for which treatment first (each treatment indicated different numbers).
Other Names:
  • Placebo taping
Placebo Comparator: Placebo taping
Placebo tapes (3M tape) were applied with same method with Kinesio taping.
This study was conducted in a randomized crossover double-blind design. Each subject was tested for muscular power, strength, endurance, and fatigue of the lower extremities under three conditions: 1) NT (no taping), 2) PT (placebo taping, 3M tape) and 3) KT (Kinesio taping). For allocation of treatment sequence, the participants drew straws for which treatment first (each treatment indicated different numbers).
Other Names:
  • Placebo taping
No Intervention: No taping
In case of the no taping condition, the subject was treated along the same procedure which was closed subject's eyes with eye mask and covered the legs with clothes although applied anything on their legs. It might be able to minimize the error, because the researchers did not realize which condition the subject had.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physique characteristic
Time Frame: 1 week (Each subject was measured their anthropometrics variables in an Initial visit the LAB for trial)
- variables:(1) Body weight and height (Detecto DR400C platform scale (Webb City, MO) and Seca S-214 height rod (Hanover, MD), respectively), (2) Waist and hip circumference (Gulik tape measure), (3) % Body fat (bioelectrical impedance analysis, RJL Quantum X).
1 week (Each subject was measured their anthropometrics variables in an Initial visit the LAB for trial)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
muscular power
Time Frame: 4 weeks (30 minutes after applied each trial)
Peak power and mean power were measured with automatic Power cycle (Powercycle, USA). The subjects started from rest and accelerated maximally for approximately 3-4 seconds. Data was recorded for 6.5 pedal revolutions, and the increase in kinetic energy resulting from the acceleration of the ergometer flywheel was averaged over every pedal revolution and used to calculate power. The highest power and mean power (average two of the highest values) recorded during a pedal revolution was defined as Pmax and Pmean respectively.
4 weeks (30 minutes after applied each trial)
muscular strength
Time Frame: 4 weeks (30 minutes after applied each trial)
Assessment of muscle strength was measured by Muscle Testing system. A hand-held dynamometer (Lafayette, USA) used to measure isometric knee extensor and flexor strength. Specifically, subjects were seated on a table in supine position, with the knee and hip positioned at 90º. The subjects were instructed to remain seated and place both hands on the table. The dynamometer force pad placed just proximal to the ankle joint, the knee extensor strength was quantified in pound force. All subjects performed two maximal trials for 3 to 5 seconds with a 30 seconds rest interval. The higher value of two trials was recorded.
4 weeks (30 minutes after applied each trial)
muscle fatigue
Time Frame: 4 weeks (immediately after be completed each trial)
To measure the sensation of lower limb muscle fatigue, subjects' subjective feelings were evaluated using a Visual Analogue Scale (VAS). A 100 mm VAS (on a 0-10 scale) was used, ranging from "not in the least (0)" on the left to "extremely (10)" on the right end. Participants were asked to score the amount of lower limb muscle fatigue experienced before and immediately after each trial.
4 weeks (immediately after be completed each trial)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sukho Lee, Ph.D., Texas A&M University San Antonio

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2015

Primary Completion (Actual)

April 1, 2015

Study Completion (Actual)

June 1, 2015

Study Registration Dates

First Submitted

May 6, 2016

First Submitted That Met QC Criteria

July 18, 2016

First Posted (Estimate)

July 21, 2016

Study Record Updates

Last Update Posted (Estimate)

July 21, 2016

Last Update Submitted That Met QC Criteria

July 18, 2016

Last Verified

July 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • Tamusa

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Kinesio taping

3
Subscribe